Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts

Eur J Cancer. 2020 Nov:140:161-162. doi: 10.1016/j.ejca.2020.09.003. Epub 2020 Sep 6.

Authors

Alice Indini¹, Erika Rijavec², Michele Ghidini², Monica Cattaneo³, Francesco Grossi²

Affiliations

¹ Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. Electronic address: alice.indini@gmail.com.
² Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
³ Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Neoplasms* / epidemiology
Pandemics*
Pneumonia, Viral* / epidemiology
Risk Assessment
SARS-CoV-2